As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...